Cargando…

The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer

Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Evcimik, Taner, Degerli, Mahmut Said, Bilgic, Tayfun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387074/
https://www.ncbi.nlm.nih.gov/pubmed/32754412
http://dx.doi.org/10.7759/cureus.8878
_version_ 1783564070530580480
author Evcimik, Taner
Degerli, Mahmut Said
Bilgic, Tayfun
author_facet Evcimik, Taner
Degerli, Mahmut Said
Bilgic, Tayfun
author_sort Evcimik, Taner
collection PubMed
description Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic factors and many studies have begun. The aim of this study is to evaluate breast cancer patients and to investigate other factors affecting breast cancer. Materials and methods Patients with breast cancer who were operated in our clinic between January 2005 and June 2007 were included in the study. Demographic characteristics, tumor size, lymph node involvement, grade, histological type, the status of estrogen and progesterone receptors (ER and PR), type of surgery performed, and cerb-B2 receptor status were recorded retrospectively. Results The mortality rate of the ER (+) PR (+) group was significantly lower than that of the ER (-) PR (-) group (p<0.05). There was no statistically significant difference between the ER (+) PR (+) cases and the mortality rates of any positive cases (p>0.05). There was a statistically significant difference between survival rates according to cerb-B2 status (p<0.01); cerb-B2 was positive in all patients who died. In cerb-B2 positive cases, there was a statistically significant difference between survival rates according to the tumor stages (p <0.05). Conclusion As a result; preoperative and postoperative staging of all breast cancer patients who applied to surgery clinics should be performed. Prognostic factors should be determined and patients should be directed to post-surgical treatment according to this information. Axillary lymph involvement, number, tumor size, estrogen receptor, progesterone receptor, and cerb-B2 status are safe markers that can be used to determine prognosis in our series.
format Online
Article
Text
id pubmed-7387074
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-73870742020-08-03 The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer Evcimik, Taner Degerli, Mahmut Said Bilgic, Tayfun Cureus Pathology Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic factors and many studies have begun. The aim of this study is to evaluate breast cancer patients and to investigate other factors affecting breast cancer. Materials and methods Patients with breast cancer who were operated in our clinic between January 2005 and June 2007 were included in the study. Demographic characteristics, tumor size, lymph node involvement, grade, histological type, the status of estrogen and progesterone receptors (ER and PR), type of surgery performed, and cerb-B2 receptor status were recorded retrospectively. Results The mortality rate of the ER (+) PR (+) group was significantly lower than that of the ER (-) PR (-) group (p<0.05). There was no statistically significant difference between the ER (+) PR (+) cases and the mortality rates of any positive cases (p>0.05). There was a statistically significant difference between survival rates according to cerb-B2 status (p<0.01); cerb-B2 was positive in all patients who died. In cerb-B2 positive cases, there was a statistically significant difference between survival rates according to the tumor stages (p <0.05). Conclusion As a result; preoperative and postoperative staging of all breast cancer patients who applied to surgery clinics should be performed. Prognostic factors should be determined and patients should be directed to post-surgical treatment according to this information. Axillary lymph involvement, number, tumor size, estrogen receptor, progesterone receptor, and cerb-B2 status are safe markers that can be used to determine prognosis in our series. Cureus 2020-06-28 /pmc/articles/PMC7387074/ /pubmed/32754412 http://dx.doi.org/10.7759/cureus.8878 Text en Copyright © 2020, Evcimik et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Evcimik, Taner
Degerli, Mahmut Said
Bilgic, Tayfun
The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title_full The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title_fullStr The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title_full_unstemmed The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title_short The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer
title_sort effect of prognostic factors on long-term protection in breast cancer
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387074/
https://www.ncbi.nlm.nih.gov/pubmed/32754412
http://dx.doi.org/10.7759/cureus.8878
work_keys_str_mv AT evcimiktaner theeffectofprognosticfactorsonlongtermprotectioninbreastcancer
AT degerlimahmutsaid theeffectofprognosticfactorsonlongtermprotectioninbreastcancer
AT bilgictayfun theeffectofprognosticfactorsonlongtermprotectioninbreastcancer
AT evcimiktaner effectofprognosticfactorsonlongtermprotectioninbreastcancer
AT degerlimahmutsaid effectofprognosticfactorsonlongtermprotectioninbreastcancer
AT bilgictayfun effectofprognosticfactorsonlongtermprotectioninbreastcancer